From a molecule of natural origin new therapeutic opportunities against hypertension
A peptide extracted from the cyanobacterium ‘spirulina’ may contrast high blood pressure by dilating blood vessels
Spirulina is more and more celebrated as a “superfood” because of its possible beneficial properties, albeit its mechanism of action is still subjected to investigation. With the scientific name of Arthrospira platensis, spirulina is a cyanobacterium, a bacterium capable of photosynthesis. Sometimes classified as a “blue algae”, it was supposedly used as a food by the Aztecs.
Now a research from the Vascular Physiopathology Laboratory of the I.R.C.C.S. Neuromed in Pozzilli (Italy) shows that one of its extracts may counteract arterial hypertension by dilating blood vessels.
Neuromed researchers, working in collaboration with University of Salerno, Sapienza University of Rome and Federico II University of Naples, isolated from the spirulina extract a peptide (a molecule composed of amino acids, such as proteins, but smaller) capable of dilating arteries, thus leading to antihypertensive action. The study, published in the journal Hypertension, was conducted both in the laboratory, on isolated arteries, and on animal models.
“Our research – says Albino Carrizzo, first author of the paper – started by conducting simulated gastrointestinal digestion on the raw extract of spirulina. In other words, we reproduced what happens in the human gut after ingesting the substance. This way we have been able to isolate the peptides that would be absorbed by our body “.
One of the isolated peptides, named SP6, has been identified for the first time. Administered to isolated blood vessels in the lab, it showed vasodilatory action, a potentially antihypertensive effect. This led researchers to administer SP6 to hypertensive animals, resulting in an effective lowering of blood pressure.
“We know – says Carmine Vecchione, Professor at the University of Salerno and head of Vascular Physiopathology Laboratory at Neuromed Institute – that hypertensive patients often have a defect in the natural processes that, by the action of nitric oxide, regulate endothelium (the inner wall of blood vessels). The peptide we isolated in spirulina extract acts positively on this mechanism. Of course, further researches will be necessary, but we think that SP6 could be a natural adjuvant to common pharmacological therapies in order to improve endothelial function and, consequently, combat hypertension”.
The I.R.C.C.S. Neuromed
The Institute for Research, Hospitalization and Health Care (I.R.C.C.S.) Neuromed in Pozzilli (Italy) is a landmark, at Italian and international level, for research and therapy in the field of nervous system diseases. A center in which doctors, researchers, staff and the patients themselves form an alliance aimed at ensuring the best level of service and cutting-edge treatments, guided by the most advanced scientific developments.